This inventor holds 22 USPTO granted patents and 3 EPO patents, primarily in Polyprenyl Compounds. Top assignees: Eisai Company, Limited, Eisai R&d Management Co., Ltd.. Active years: 1985-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yatabe, JP (1986)
- Yatabemachi, JP (1986 - 1989)
- Yatabecho, JP (1994)
- Tsukuba-gun, JP (2000)
- Ibaragi, JP (1985 - 2001)
- London, GB (1998 - 2001)
- Ibaraki, JP (1995 - 2004)
- Tsukuba, JP (2007)
Company Filing History:
Years Active: 1985-2007
Areas of Expertise:
Title: The Innovative Contributions of Akiharu Kajiwara
Introduction: Akiharu Kajiwara, based in Yatabemachi, Japan, is a prolific inventor known for his significant contributions to the field of chemistry. With an impressive portfolio of 22 patents to his name, Kajiwara has demonstrated a consistent commitment to innovation and research.
Latest Patents: Kajiwara's recent inventions include two noteworthy compounds. The first is a 2-iminoimidazole derivative, characterized by a complex molecular structure involving various substituents, including hydrogen and alkyl groups. The second patent features a 2-iminopyrrolidine derivative with similar complexity, involving benzene or pyridine rings and a variety of functional groups. Both compounds, or their respective salts, showcase the inventive prowess that Kajiwara brings to the scientific community.
Career Highlights: Throughout his career, Akiharu Kajiwara has been associated with leading organizations in the pharmaceutical industry such as Eisai Company, Limited and Eisai R&D Management Co., Ltd. His work in these companies has been pivotal to the advancement of novel therapeutic compounds.
Collaborations: Kajiwara has collaborated with several esteemed colleagues, including Takeshi Suzuki and Isao Yamatsu. Together, they have worked on various projects that reflect their dedication to enhancing drug development and innovative solutions in the field of medicine.
Conclusion: Akiharu Kajiwara's contributions to science and innovation are marked by his extensive patent portfolio and collaborative efforts in the pharmaceutical industry. His latest inventions illustrate his expertise and commitment to creating advanced solutions that can potentially lead to significant improvements in healthcare. Through continued collaboration and innovation, Kajiwara is set to further influence the field of chemistry and pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile